Keywords: MPP +، 1-Methyl-4-phenylpyridinium; BS, brassinosteroids; CC50, 50% cytotoxic concentration; EBl, 24-epibrassinolide; EC50, half maximal effective concentration; HSV, herpes simplex virus; HBl, 28-homobrassinolide; MPP+, 1-methyl-4-phenylpyridinium; TNF-α, tumor necrosis factor αBrassinoste
مقالات ISI MPP +، 1-Methyl-4-phenylpyridinium (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; αsyn, alpha-synuclein; CK, casein kinase; GFP, green fluorescent protein; LDH, lactate dehydrogenase; LRRK2, leucine-rich repeat kinase 2; MPP+, 1-Methyl-4-phenylpyridinium; n.s, not significant; PD, Parkinson's disease; PBS, phosphate-buffered saline; SN
Hydroxytyrosol induces phase II detoxifying enzyme expression and effectively protects dopaminergic cells against dopamine- and 6-hydroxydopamine induced cytotoxicity
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; Hydroxytyrosol; Parkinson's disease; Dopamine; Oxidative stressPD, Parkinson's disease; DA, Dopamine; DAQ, Dopamine quinone; HT, Hydroxytyrosol; SF, Sulforaphane; 6-OHDA, 6-Hydroxydopamine; MPP+, 1-Methyl-4-phenylpyridinium; ROS, Reactive oxygen species;
The neuroprotective effect of lovastatin on MPP+-induced neurotoxicity is not mediated by PON2
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; MPP+, 1-methyl-4-phenylpyridinium; PD, Parkinson's disease; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydrophenylpyridine; MAO-B, monoamine oxidase B; DA, dopamine; ROS, reactive oxidant species; PON2, paraoxonase-2; HVA, homovanillic acid; DOPAC, 3,4-dihydrox
Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium; 3-MT, 3-methoxytyramine; MHPG, 3-methoxy-4-hydroxyphenylglycol; DOPAC, 3,4-dihydroxymethylphenylacetic acid; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytryptami
Tissue transglutaminase cross-links beclin 1 and regulates autophagy in MPP+-treated human SH-SY5Y cells
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; PD, Parkinson’s disease; MPP+, 1-methyl-4-phenylpyridinium; tTG, tissue transglutaminase; ER, endoplasmic reticulum; LBs, Lewy-bodies; RA, retinoic acidParkinson’s disease; Autophagy; SH-SY5Y; Tissue transglutaminase; Beclin 1; Endoplasmic reticulum
Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; MPP+, 1-methyl-4-phenylpyridinium; 4-PBA, 4-phenylbutyrate; AD, Alzheimer's disease; Aβ, amyloid-beta peptide; APP, β-amyloid precursor protein; HAT, histone acetyl transferase; HDACs, histone deacetylases; HD, Huntington's disease; PD, Parkinson's diseas
Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: Relevance to Parkinson’s disease
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; ER, endoplasmic reticulum; FBS, fetal bovine serum; HtrA2/Omi, High temperature requirement A2; MMP-3, matrix metalloproteinase-3; MPP+, 1-methyl-4-phenylpyridinium; PD, Parkinson’s disease; RT-PCR, reverse transcription-polymerase chain reactionHtrA2/Omi
Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; CD68, cluster of differentiation 68; FACS, registered trademark of Becton Dickinson and Company; FITC, fluorescein isothiocyanate; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MAC-1, macrophage antigen complex-1; MPP+, 1-methyl-4-phenylpyridinium; MPT
Genetically engineered mouse models of Parkinson's disease
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; MPTP, 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium; 6-OHDA, 6-hydroxydopamine; COMT, catechol-O-methyltransferase; DA, dopamine; DAT, dopamine transporter; L-DOPA, levodopa; LB, Lewy body; LPS, lipopolysaccharride; MAOB,
Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; E217βG, estradiol-17β-glucuronide; MPP+, 1-methyl-4-phenylpyridinium; OATP1B1/3, Organic Anion Transporting Polypeptide 1B1 and 1B3; SLCO, Solute carrier organic anion transporter; SLC, Solute Carrier; OCT1, Organic Cation Transporter 1Cryopreserved hepat
Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; ANOVA, one way analysis of variance; Ct, threshold cycles; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; JNK, c-Jun N-terminal kinase; LDH, lactate dehydrogenase; MPP+, 1-methyl-4-phenylpyridinium; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazol
Myricetin attenuated MPP+-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; Myricetin; MPP+; Oxidative stress; MKK4MPTP, 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide; JNK, c-Jun N-terminal kinase; DA, dopamine; DMEM/F12, Eagl
Deprenyl prevents MPP+-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K/Akt and Erk
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; PD, Parkinson's disease; ROS, reactive oxygen species; ARE, antioxidant response element; Nrf2, nuclear factor erythroid 2-related factor 2; MAO-B, B-type monoamine oxidase; NQO1, NAD(P)H quinone oxidoreductase 1; MPP+, 1-methyl-4-phenylpyridinium; Erk, e
Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; CHHS, cryopreserved human hepatocyte suspensions; E2-17β-G, etradiol-17β-d-glucuronide; MPP+, 1-methyl-4-phenylpyridinium; NTCP/Ntcp, Na+-taurocholate co-transporting peptide (Human/Rat); OAT/Oat, organic anion transporter (Human/Rat); OATP/Oatp, organic
Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; DA, Dopamine; PD, Parkinson's disease; MPP+, 1-methyl-4-phenylpyridinium; HDACs, Histone deacetylases; HDACIs, Histone deacetylase inhibitors; NaB, Sodium butyrate; VPA, Valproic acid; SAHA, Suberoylanilide hydroxamic acid; IAP's, Inhibitors of Apoptosis;
Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; Parkinson's disease; 1-Methyl-4-phenylpyridinium (MPP+); Divalent metal transporter 1 (DMT1); NF-κB; Rg1SN, substantia nigra; SNpc, substantia nigra pars compacta; PD, Parkinson's disease; MPP+, 1-methyl-4-phenylpyridinium; DMT1, divalent metal transporte
Reactive oxygen species regulation by AIF- and complex I-depleted brain mitochondria
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; AIF, apoptosis-inducing factor; Dld, dihydrolipoamide dehydrogenase; DNP, 2,4 dinitrophenylhydrazone; DNPH, 2,4 dinitrophenylhydrazine; DTNB, 5,5′-dithiobis-(2-nitrobenzoic acid); Hq, harlequin; MPP+, 1-methyl-4-phenylpyridinium; SOD, superoxide dismutase
Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: Gain-of-function by interchange of selected amino acids
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; CT, carnitine; CTT, carnitine transporter; ET, ergothioneine; ETT, ergothioneine transporter; LC, liquid chromatography; MPP+, 1-methyl-4-phenylpyridinium; MS, mass spectrometry; TMS, transmembrane segmentCarnitine transporter; Ergothioneine transporter;
Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; SN, substantia nigra; PD, Parkinson's disease; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; DMT1, divalent metal transporter 1; IRE, iron responsive element; TfR, transferrin receptor; UTR, untranslational region;
Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; AFR, ascorbate free radical; CNS, central nervous system; CSF, cerebrospinal fluid; DHA, dehydroascorbic acid; GLUT, glucose transporter; GSH, glutathione; HIF-1α, hypoxia-inducible factor 1α; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2
Mitochondria and ubiquitin-proteasomal system interplay: Relevance to Parkinson's disease
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; DAergic, dopaminergic; DCFH2DA, 2,7′-dichlorofluorescein diacetate; ETC, electron transport chain; LBs, Lewy bodies; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine; mtDNA, mitochondrial DNA; NT2, human teratocarcinom
Nitration of soluble proteins in organotypic culture models of Parkinson's disease
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; AMPT, α-methyl-p-tyrosine; DA, dopamine; DOPA, 3,4-dihydroxyphenylalanine; HBSS, Hanks balanced salt solution; LDH, lactate dehydrogenase; l-NAME, N-nitro l-arginine methyl ester; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahyd
Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; Mg, magnesium; MPP+, 1-methyl-4-phenylpyridinium; PD, Parkinson disease; TH, tyrosine hydroxylaseMagnesium; 1-methyl-4-phenylpyridinium; Dopaminergic neuron; Ventral mesencephalic–striatal co-culture; Parkinson disease
Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; 6-OHDA, 6-hydroxydopamine; BBB, blood–brain barrier; DA, dopamine; DAergic, dopaminergic; DDC, diethyldithiocarbamate; Fe–S, iron–sulfur; GSH, glutathione; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NOS, nitric
Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; ETT, ergothioneine transporter; LC, liquid chromatography; MPP+, 1-methyl-4-phenylpyridinium; MS, mass spectrometry; TEA, tetraethylammoniumSLC22A4; Chronic inflammatory disease; Ergothioneine; Ergothioneine transporter; Methimazole; Organic cations
17β-Estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; DAB, 3,3′-diaminobenzidine tetrahydrochloride; E2, 17β-estradiol; -IR, immunoreactive; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NT, nitrotyrosine; PBS, phosphate buffered saline; PD, Parkinson's disease; SEM,
Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; cortex; dendrite; glutamate; MPP+; Parkinson’s disease; striatumDIV, days in vitro; HVA, homovanillic acid; ir, immunoreactive; MPP+, 1-methyl-4-phenylpyridinium; MSN, medium spiny neuron; PD, Parkinson’s disease; TBS, Tris-buffered saline; TBS+, 50 mM Tr
The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; OCT3, organic cation transporter-3; METH, methamphetamine; OCT3-AS, antisense against OCT3; OCT3-SCR, scrambled antisense against OCT3; PFC, prefrontal cortex; NAcc, nucleus accumbens; MPP+, 1-methyl-4-phenylpyridinium; CP, choroid plexus; CSF, cerebrospi
Comparative analysis of the effects of resveratrol in two apoptotic models: Inhibition of complex I and potassium deprivation in cerebellar neurons
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; cerebellar granule cells; resveratrol; sirtinol; SIRT1; MPP+; serum and potassium withdrawalCGN, cerebellar granule neuron; Ct, cycle threshold; H2DCFDA, 2,7-dichlorodihydrofluorescein diacetate; MPP+, 1-methyl-4-phenylpyridinium; PBS, phosphate buffered
Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; cyclin dependent kinases; apoptosis; cerebellar granule cells; flavopiridol; vitamin EAIF, apoptosis-inducing factor; CGN, cerebellar granule neuron; FLAV, flavopiridol; H2DCFDA, 2,7-dichlorodihydrofluorescein diacetate; MPP+, 1-methyl-4-phenylpyridinium;
(−)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; 6-OHDA, 6-hydroxydopamine; DAT, dopamine transporter; EGCG, (−)-epigallocatechin gallate; MPP+, 1-methyl-4-phenylpyridinium; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; Sulfo-NHS-SS-Biotin, sulfosuccinimidyl 2-(biotinamido)-ethyl-1, 3-dit
Enhancement of tyrosine hydroxylase expression and activity by Trypanosoma cruzi parasite-derived neurotrophic factor
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; PDNF, parasite-derived nerve factor; TH, tyrosine hydroxylase; MPP+, 1-methyl-4-phenylpyridinium; MAPK, mitogen-activated protein kinase; Erk, extracellular signal-regulated kinase; PKA, cAMP-dependent protein kinase A; NGF, nerve growth factorParasite-de
The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor
Keywords: MPP +، 1-Methyl-4-phenylpyridinium; DIC, differential interference contrast; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson’s disease1-Methyl-4-phenylpyridinium; Microtubule; Dynamics; Cytoskeleton; Neurodegeneration; Parkinson’s disease